Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis

By Zhang Xiaoping   Morcos Peter N   Saito Tomohisa   Terao Kimio  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 123-137

Informa Healthcare

Access to resources Recommend Favorite

Tocilizumab reduces disease activity in patients with systemic-onset juvenile idiopathic rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Treatment strategies for juvenile idiopathic arthritis

By Klein Ariane   Horneff Gerd  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. : 3049-3060

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis)

By Agle Lucila MA   Rosenkranz Margalit   Lehman Thomas JA  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 1, 2003-01 ,pp. : 19-28

Informa Healthcare

Access to resources Recommend Favorite

Recommendations for the Use of Methotrexate in Juvenile Idiopathic Arthritis

By Niehues Tim   Lankisch Petra  

Pediatric Drugs, Vol. 8, Iss. 6, 2006-01 ,pp. : 347-356

Adis International

Access to resources Recommend Favorite